IH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
iHuman Inc (IH) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of significant positive catalysts, weak financial performance in the latest quarter, and absence of strong trading signals suggest that holding off on investment is prudent.
The MACD is slightly positive and expanding, indicating mild bullish momentum. However, the RSI is neutral at 52.272, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 1.769, with resistance at 1.849 and support at 1.689. Overall, the technical indicators do not strongly support a buy decision.
The EPS has increased significantly YoY by 344.44%, which is a positive sign of profitability improvement.
Revenue and net income have both dropped significantly YoY (-14.05% and -14.15%, respectively). Gross margin has also slightly declined. There are no significant hedge fund or insider trading trends, no recent news, and no recent congress trading data.
In Q3 2025, revenue dropped by 14.05% YoY to $205.76M, and net income dropped by 14.15% YoY to $21.59M. However, EPS increased by 344.44% YoY to 0.4, indicating improved profitability despite declining top-line and bottom-line figures. Gross margin slightly declined to 68.35%.
No data available on analyst ratings or price target changes.
